Agenus Inc. (AGEN) vs Orchestra BioMed Holdings, Inc. (OBIO)

A side-by-side comparison of Agenus Inc. and Orchestra BioMed Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AGEN vs OBIO

growth of $100 · dividends reinvested · last 6y
AGEN -85.4% (-27.4%/yr)OBIO -47.1% (-10.1%/yr)OBIO compounded faster over this window
050100150200Start $100202120222023202420252026$15$53
AGEN OBIO

AGEN vs OBIO: by the numbers

  • •OBIO is the larger company ($353M vs $324M market cap).
  • •AGEN is profitable (69.34% net margin) while OBIO runs a net loss (-184.60%).
  • •OBIO grew revenue faster over the past five years (148.45% vs 14.13% CAGR).

Metrics side by side

Valuation

MetricAGENOBIO
P/E ratio2.94N/A
Forward P/E29.07N/A
P/S ratio2.4411.04
P/B ratioN/A18.27
EV / EBITDA8.45N/A

Profitability

MetricAGENOBIO
Gross margin29.63%99.32%
Operating margin-18.00%-154.73%
Net margin69.34%-184.60%
ROEN/A-200.64%
ROICN/A-56.73%

Growth (annualized)

MetricAGENOBIO
Revenue CAGR (5Y)14.13%148.45%
Total return CAGR (5Y)-40.10%-9.35%

Frequently asked

Which has grown faster, AGEN or OBIO?
Over the past five years, OBIO grew revenue faster — AGEN at a 14.13% CAGR versus OBIO at 148.45%.
Is AGEN or OBIO more profitable?
AGEN runs the higher net margin — AGEN at 69.34% versus OBIO at -184.60%.
How have AGEN and OBIO total returns compared?
Over the past 5 years, AGEN delivered -40.10% and OBIO delivered -9.35% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.